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In the thesis, we built a genome-wide polyadenylation map with sequencing data sets from various 
human tissues and cell lines. With the map, we analyzed the pattern and distribution of 
polyadenylation sites in human genome. And we explored the differential polyadenylation patterns 
of non-coding and novel genes. Meanwhile, we have created the Expression and Polyadenylation 
Database (xPAD) as a web portal for the polyadenylation map. Moreover, we revealed the 
regulatory marks that might correlated with polyadenylation sites we have found.  
  Besides, we unveiled a novel group of small YB-1 associated RNAs and investigate their 
possible regulation mechanism where we found multiple transcription factors and histone 
modification may mark the location of YB-1 associated RNA. 
We also implemented an Assembly-based Sequencing data Encoding Tool, AbSEnT. With 
this tool, we exhibited the feasibility and efficiency of the novel assembly-based compression 
algorithm by achieving a higher compression ratio than general-purpose compression tools. 
Meanwhile, we investigated the distribution of word frequency in sequencing data and found it 
shares a similarity with natural languages we used. If the connection could be proved, we may 
borrow the knowledge and experience from what we have learned in the research of natural 
language into the analysis of sequencing data. 
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1.0  INTRODUCTION 
1.1 OVERALL GOALS AND SPECIFIC AIMS 
Cells make various types of primary and processed RNAs in the course of expressing the encoded 
genetic information in genomes. The produced RNAs carry a significant portion of the 
responsibility of directing the synthesis of proteins and regulating cell behavior and gene 
expression. Thus, the synthesis, processing, transport, modification and translation of RNAs reveal 
us how the genetic information is utilized and the cell functions. However, the complete landscape 
of these RNAs is not readily available and the different characteristics of them are still poorly 
understood. Therefore, we aim to construct a complete transcriptional landscape of the human 
genome and further investigate patterns and characteristics of previously unannotated RNAs. In the 
meantime, due to the fact that massive sequencing data are generated in the field, the problem of 
data storage and share hinders the fast-pace development of the field. To accommodate it, we 
expect to develop a novel computational method to efficiently compress sequencing data.  
1.1.1 Compressing sequencing data with assembly-based algorithm 
We compressed large next-generation sequencing (NGS) data to efficiently store and transfer data 
sets. Specifically, we aim to construct an assembly-based compression method. Unlike the existing 
method that using available curated genome, we used a genome assembled directly from each 
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dataset by de-novo assembler, which would be suitable when a high-quality reference is not 
available or the sequencing is made on a mixture of samples from multiple and might be unknown 
genomes. We compressed not only the sequence data but also quality and read identifier data all 
together. The method was superior to general-purpose compressor, e.g. gzip or bzip2, in term of 
compression ratio on our test data set. We also targeted to implement the method as a publicly 
available software package.  
• Assemble a virtual genome as reference assembly from sequencing data with de-novo 
assembler; 
• Develop assembly-based method to compress read identifiers, sequences and quality data 
separately; 
• Implement assembly-based method as a publicly available software package. 
1.1.2 Building comprehensive polyadenylation map of human genome 
To facilitate investigation of polyadenylation patterns in normal and tumor human cells, we built an 
open-access community resource using Direct RNA sequencing (DRS)1 with multiple experiments 
of different tissues and cell lines. The resource showed cell type-dependent polyadenylation map, 
helped the comparison of polyadenylation patterns among various tissues and cell lines, and 
facilitated the discovery of novel genes and gene isoforms that might potentially important to 
tumorigenesis. The resource is publicly accessible through a web portal, which not only provides 
direct comparison of the pattern of polyadenylation sites across various tissue/cell types, but also 
enables users to search, download and analyze the data of their interest.  
• Build polyadenylation map from sequencing data of various human tissues and cell lines; 
• Develop a web portal of polyadenylation map for easy access and direct comparison; 
• Analyze and discover differential polyadenylation patterns of non-coding and novel genes. 
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1.1.3 Characterizing a novel group of short RNAs that associates with YB-1 
We found the multifunctional nucleic acid binding protein, Y-box binding protein 1 (YB-1), is 
associated with two distinct but related classes of RNAs in a pilot study. Our goal is to characterize 
the novel group of RNAs and explore their biogenesis and regulation mechanisms. We investigated 
the relationship between these RNAs with Illumina and Helicos sequencing techniques. We also 
researched the relationship of these RNAs with annotated genomic marks to identify the 
mechanisms that control their biogenesis. 
• Analyze the relationship between two novel classes of YB-1 associated RNAs; 
• Investigate the relationship between the YB-1 associated RNAs and various annotated 
genomic marks, including histone marks, transcription factor binding sites and small RNAs. 
1.2 BACKGROUND AND SIGNIFICANCE 
1.2.1 Gene expression analysis using next-generation sequencing 
Gene expression is the fundamental process of cell, by which information flow from genome to 
corresponding functional product. Genetic information stored in genome is expressed through 
multiple steps, including transcription and RNA processing; and if the product is protein, more 
steps like translation and post-translational modification are required. All these products work as 
structural and functional components of cell, or serve as regulation factors to give control over 
different machineries of cell. Therefore, measuring gene expression level genome-wide is of great 
value to understand the various mechanisms in cells, including gene regulation and cancer 
development.  
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Before next-generation sequencing techniques, gene expression profiling is first practically 
done by microarrays. As the most commonly used high-throughput screening method a decade ago, 
microarrays enable the monitoring of thousands of genes at a time and have provided a huge 
amount of information about gene expression in human that are unknown before. However, this 
technique has two disadvantages. One is that the range of detected signal is limited to several 
orders from the minimum to the maximum; the other is that the locations on the genome that it can 
study are restricted to known genes. The next-generation sequencing technique overcomes these 
shortcomings in that it can detect the gene expression signal by hit counts that are ranged from 0 to 
the theoretically unlimited; and it can detect transcripts anywhere from the whole genome. 
Therefore, the next-generation sequencing techniques offer the opportunity of revealing 
comprehensive landscape of transcripts, including splicing variants, identifying novel transcripts as 
well as quantifying their expression levels in a given sample. Although it increases the challenge of 
data analysis and rebuilding transcript models, the next-generation sequencing techniques have 
been able to expand gene expression profiling to genome-wide expression analysis, from annotated 
gene regions to the whole genome, including previously underestimated non-coding RNAs.   
1.2.2 Non-coding RNAs  
It is clear that a large portion of the human genome is transcribed. However, we have not yet 
addressed a key question. Are the transcribed sequences functional or are they merely 
transcriptional noise such as random products and degradation-resistant RNAs?  
When we look back the history, it must be noted that when the first miRNA, lin-4, was 
discovered more than a decade ago, it was generally believed that such small RNAs are not wide-
spread. It took approximately another ten years to realize that miRNAs are a large class of 
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functionally important non-coding RNAs (ncRNAs) and several of them are strongly involved in 
cancer pathways2,3,4. Several reports unequivocally demonstrate that a very large number of 
ncRNAs have important roles in mammals. Also, a large fraction of the reported transcripts 
generally have polyA tails, have experimentally verified transcription factor binding sites near their 
genomic loci, and appear to be spliced5,6. Several of the reported transcripts were verified by 
northern-blot analysis or real time RT-PCR, thereby revealing their relatively high abundance. 
Although some of these transcripts may have protein-coding regions that were not previously 
annotated, many do not appear to have any significant coding potential7,8,9. Moreover, the emerging 
role of large numbers of miRNAs in genome-wide regulation of protein-coding genes, their tissue 
specific expression patterns, and their roles in diverse pathways are excellent examples for the 
wide-spread expression and influence of ncRNAs. 
In light of realization that many functional ncRNAs have been identified in a variety of 
species, it is reasonable to postulate that the human genome encodes a large number of ncRNAs 
involved in numerous processes. The continuing discoveries of ncRNAs using NGS strategies are 
beginning to unravel many surprises in molecular biology. Based on multiple independent 
observations that indicate that the extent of the genome transcription is much greater than 
previously thought, we must no longer ignore the possibility that ncRNAs and other genomic 
products that are yet uncharacterized may help unravel the central events that lead to cancer. 
1.2.3 Technology challenges in next-generation sequencing 
With the fast evolving in recent years and many advantages it bears, NGS becomes the method of 
choice nowadays in genome and transcriptome analysis. Meanwhile, many big projects, for 
example The 1000 Genomes Project10 and Genome 10K11, have been launched to study a 
 6 
comprehensive overview of genomes and aim to understand various mechanisms of cells and life 
complexity. These large-scale projects produce terabytes of sequencing data daily for storage and 
distributing to clients and collaborators. Moreover, the cost of NGS dropped in recent years at a 
pace far outstripping Moore’s law12, which describes the pace of the growth of computing power. 
These trends boost the data accumulation speed dramatically and introduce a huge pressure and 
challenge on how to efficiently store and manage these data with limited budget and share them 
with scientists all over the world within a reasonable time.  
1.2.4 Basic algorithm of data compression 
Given these trends and challenges, compression of NGS data seems to be a natural direction to 
pursue. Currently, the most commonly used compression strategy of these raw sequencing datasets 
is applying the general-purpose compressors, for example, gzip and bzip2. These methods have the 
advantages of ease of use and broad applicability. The compression ratio, however, is far from 
optimal as the specific properties of sequencing data are not fully utilized. Thus, novel compression 
methods that are optimized for sequencing data need to be explored and applied to solve the data 
storage and sharing challenge in the field.   
There are two main approaches in data compression. One approach, including dictionary 
coders and entropy compressors, is to build a statistical model to represent data efficiently by 
exploiting redundancy. For example, Lempel-Ziv (LZ) compression methods, one category of 
dictionary coders, compress data by replacing repeat occurrences of data with references to a 
dictionary that is built on based on input data stream. These coders form the basis of many 
ubiquitous compression schemes, including the algorithms used in gzip, GIF and PNG. The 
entropy compressors, including Huffman and arithmetic coders, compress data by encoding higher 
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frequent patterns with shorter bit strings and low frequent patterns with longer bit strings. The 
utilization of these coders is universal, including the back-end algorithm for JPEG, MP3 and many 
others.  
The other data compression approach is data differentiation, which produces a difference 
given a source and a target as compression, and then represents the target by patching the source 
with the difference produced as decompression. Delta encoding, which records the relative change 
between sequential data instead of the complete files, roots in this idea. These methods are widely 
used in data synchronization and version control. Despite the conceptual difference between these 
approaches, applications of compression algorithms generally mix up multiple methods, hoping for 
fully utilizing their advantages under different circumstances.  
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2.0  COMPRESSING SEQUENCING DATA WITH ASSEMBLY-BASED ALGORITHM 
2.1 INTRODUCTION 
2.1.1 Sequencing Data Accumulation 
In recent years, the fast development next-generation sequencing technology (NGS) has made this 
technology vastly and successfully used in multiple biological research fields, such as genome and 
transcriptome analysis, Copy-number Variantion (CNV), Single-nucleotide polymorphism (SNP), 
alternative splicing detection and many more. With the progress in the sequencing techniques, 
more researchers migrate from traditional microarray technology, which generates megabytes of 
data per experiment, to NGS technology, which produces gigabytes, if not more, of data per 
experiment, e.g. there would be ~100 GB result data in a Illumina HiSeq 2000 instrument run. 
When researchers enjoy the advantage of much more detail information of genome and cells, they 
have to suffer the vast increase of data. Currently, the accumulation speed of NGS data is much 
faster than the increase of computing power, which empirically obeys Moore’s law12. Given the 
situation that researchers are optimistic and yearn to personalize medicine and have put a huge 
effort to reduce the cost of sequencing to $1000 per genome, they may first face the obstacle of 
how to effectively handling these huge and even fast increasing data. 
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Figure 1. Sequencing Data Accumulation. The increase of data accumulation in the Short Read Archive (SRA) 
shows an exponential growth over the past decade. The capacity of SRA database has grown 100k times in the past 5-6 
years, from 0.02 terabases in the middle of 2008 to now more than 2.7k terabases in July 2014 .  
The first realistic problem is data storage. With data accumulating, extra computing 
infrastructure and man power has to be added and maintained. Further data analysis may require 
much more capacity to store the intermediate and final results. Another problem with huge volume 
of data is data sharing and transferring. Researchers tend to utilize data from colleagues to support, 
supplement or verify their own experiments. However, facing the huge NGS data, one may find it 
is a nightmare to transfer data back and forth through network.  The rapid growth of the data gives 
the whole community great pressure, both for scientists and engineers, on store, analyze and 
interpret these huge data. For a centralized database which provides NGS experiment data storage, 
like SRA, the demand to solve these two problems seems more urgent. In 2011, NCBI announced a 
date for terminate SRA service due to the shortage of funding, which remind the community of a 
potential problem for maintaining the public data effectively and efficiently. It cannot be imagined 
that scientists cannot find the raw and processed sequencing data of peers from the public sector, 
which is essential resource for them to peer review or cross-validate other’s results. Although, 
NCBI cancelled the decision later on, and has continued providing the archive for public access in 
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the following years, the situation still needs enough attention and effort from all related staffs from 
biological science, bioinformatics and computer science, until it can be solved.  
2.1.2 Possible Solutions 
There are three ways to solve these problems. One is discarding the sequencing data but keep the 
original sample of the experiment. It is, however, unrealistic in most cases. Since NGS is still not 
cheap enough to redo multiple times now, it is a waste of funding to discard the result. Also, data 
sharing among researchers is impossible after data discarding. Keeping the sample consistent over 
time is also a challenge. Another way to deal with huge NGS data is reducing the size or format of 
the original data, for example, decreasing the level of quality data. However, it may affect the 
signal to noise ratio of experiment and need further research to verify the feasibility.  The third way 
is compressing the raw NGS data. The reduction of data set size would allow more data being 
stored and less data transfer lapse. This approach is currently the most feasible method to solve 
data storage and transfer problem of NGS data sets.  
2.1.3 Redundancy in the sequencing data set 
The compression of nucleotides sequences has been studied in the past decades. The compression 
of NGS data sets, however, is a relevant but different topic. The relevance between these topics 
roots in the fact that they both target compressing nucleotides sequences, which are comprised of 
four kinds of nucleotides, which are A, C, G and T, and probably an extra wildcard, N, which 
stands for missing or unidentified nucleotide. The difference comes from the distribution and 
characteristic of data. Compression of nucleotide sequences targets a small number of long 
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sequences, while NGS data compression targets a large amount of, usually millions of, short reads. 
Also, the NGS data compression involves handling accessory information of each read, such as 
read identifier and quality data.  
To compress a dataset, the vital thing for considerration is to explore the special properties 
of the subject of the research and choose effective and efficient algorithms that are designed to 
pinpoint and utilize that property to perform for a high compression ratio. For example, in the 
compression of images, a straight forward presentation of image is matrix of pixels, in which each 
pixel stores various properties of that spot, such as grayscale, color channels and so on. 
Theoretically, images can be any random matrix of pixels; but in reality, there are always some 
patterns for a meaningful picture: e.g. pixels are locally correlated in most cases, meaning that the 
adjacent pixels share similar properties, including but not limit to color and grayscale, which is an 
important property that can be utilized by image compression algorithms. The correlationship 
indicates information redundancy in the straightforward storage format, which gives the space for 
compression to come in to store information in another format to gain high efficiency in storage by 
sacrisfing native storage format. 
In sequencing datasets, the native format for gene sequences is a set of strings of A/C/G/T 
characters, reperesenting corresponding nucleotides. These sequences of nucleotides in cell do not 
come from a purely uniform distribution. And when they store, deliver and express the information 
within genome, the expression level could be vary in several magnitudes, which makes the presents 
of each nucleotides and short reads quite different. Thus, some sequences which have just more 
occurrences or are easier to be transcribed than the others in the genome would results in a large 
amount of repeat in the data set, the fact of which leads to an imbalance of these occurrence 
numbers in experiment result and could be a vital feature that can be utilized in data compression. 
Other than that, in next-generation sequencing datasets, all short reads come from a single or 
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several genomes with only subtle variation here and there. And these millions of reads overlap with 
other reads by part or whole to increase the coverage and fidelity of the sequencing experiment, 
which inevitably lead to the fact that a large of fraction of the information stored is redundant.  
2.1.4 Available Frameworks and Tools 
To handle short reads in NGS data sets, several methods have been put forward in recent years. The 
most straight forward and widely-used method is taking advantage of existing general purpose 
compressors, e.g. gzip or bzip2, directly. This approach bears several advantages, including ease of 
use and wide adaptability, since any data set can be compressed with these tools regardless of the 
format or completeness. The main disadvantage, however, is the compression efficiency, since 
these methods do not make use of any specific NGS data property, such as the short reads are 
derived from longer nucleotide sequences. Thus, many NGS data oriented tools have been designed 
in recent several years to answer the quest. 
Reference-based framework, which based on the assumption that most short reads 
generated in the NGS data set comes from a set of longer sequences, which can be called as 
reference sequences, is the most developed method to handle exponential growing NGS data sets 
nowadays. In reference-based framework, all short reads from NGS data set are first aligned to a 
specific reference, e.g. GRCh37/hg19 when the NGS data set is generated from human sample, and 
only the locations and differences of hit on the reference are recorded, while the original read 
sequences are discarded; then the information of aligned reads and unalignable read sequences are 
further encoded with statistical compression method. In the aligning part, the sequences 
information is converted into position information, which is supposed to be more concise and 
easier to compress under statistical method. In the process, the reference genome works as a 
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dictionary in Lempel-Ziv compression method, and save the space to record the shared information 
between data set and reference.  
A bunch of tools have been developed under this framework in the last several years.  One 
of these tools is CRAMtool13, which is a set of Java tools and APIs for efficient compression of 
sequence read data sets that developed by EMBL-EBI. It follows the principle and framework that 
described in [13], and is developed with the objective of achieving better loseless compression than 
BAM, which is a compressed binary file format of SAM to store aligned nucleotides sequences. 
While the main target is to keep archive lossless, CRAMtool also provide the options of lossy 
compression strategies of data set to enable users to make choice of whch data should be preserved 
in the archives.  Currently, CRAMtool is utilized by SRA as a comparative compression method to 
reduce the size of some sequencing data sets compatible with the method. 
Besides, there are several other compression tools that are designed for a close related 
problem that is, archiving genome, one of which is Genome Differential Compressor (GDC)14. The 
algorithm behind GDC is to compress multiple genomic sequences that comes from same or 
similar species by choosing one of the sequences as a reference and encode the variance of the 
other sequences to the reference sequence with a carefully designed LZ-77 scheme. There are 
several other tools, such as Genome Re-Sequencing(GRS)15, Genome Re-sequencing Encoding 
(GReEN)16, , GenomeZip17,  that adopt similar philosophy to squeeze data sets. While bearing the 
advantage of high compression ratio and fast compression speed, these tool has a limited usage 
scope for modern large scale sequencing data sets, as the reads in these sequencing data are short 
ones, not as long as genomes used by the tool making choose one data set as reference problematic; 
and the difference among short reads data sets is much higher than long genomic sequences making 
a great loss of the compression ratio and efficiency. 
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Recently, other than reference-based framework, several statistical compression methods 
that tailor to NGS data have also been proposed, such as DSRC18 and G-SQZ19. These tools divide 
the FASTQ files and compress them independently with LZ-based or Huffman coding approaches. 
Although they can only handle FASTQ files, these methods show a better compression ratio (×1.1-
1.5)18,19 than the general-purpose compressors. Another tool, Quip20, which is based on statistical 
model using arithmetic coding, can handle both FASTQ and SAM/BAM format and is able to 
achieve an even better compression ratio (×1.5-2)20.  
2.1.5 Advantages and disadvantages 
The advantage of reference framework is extremely obvious in re-sequencing data set, since this 
type of data set comes from a defined set of reference sequences, e.g. human or Arabidopsis 
thaliana genome, and the reference genomes are widely available and verified. The high quality of 
reference genome increase the chance of hit when we try to align short reads back to these 
references. The disadvantage of the framework lies in the fact that it is highly reliance on reference 
quality and availability. For species that do not have high quality annotated genome, the method 
may fail because of a low percentage of reads can be aligned to the reference genome, which 
heavily affect the compression ratio of the scheme. Moreover, many NGS data sets are sequenced 
with a biological sample consisted of different species, which may not be known or identified 
beforehand, e.g. the data sets of Human Microbiome Project21. Under such circumstance, no 
reference is available, which make the reference-based compression scheme not applicable. 
Another issue to be considered is that the versions of references being used in various archives 
need careful management. With more researches and experiments performed, the annotated 
genomes that are used as references may be updated so frequently that either older versions of 
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references need to be maintained in publicly database or the compressed archives would be updated 
for each new version of references, which would be a huge hassle or waste of computing power. 
Moreover, with many curated genome sequences available in public databases, the methods 
of differential encoding become feasible, including the algorithm13 on which the developing 
CRAM tool is based. These methods are generally reference-based and implemented with two 
stages. First, reads are mapped to various locations on publicly available genome sequences. 
Afterwards, these locations, as well as the mismatches between reads and reference genome, are 
recorded and further compressed. The philosophy behind this method is the same as delta 
encoding. An extreme example of this application is DNAzip22, with which James Watson’s 
genome was compressed to a file of size ~4 MB, with the aid of curated human genome22. The 
strength of the reference-based method is that the reference genome can be stored in publicly 
accessible database, instead of each compressed file, to save space. The weak points, however, are 
that the compressed files are not self-contained, making decompression complicate; and the method 
suffers when a close related reference is not readily available for the data set.  
Besides, with complete genome sequencing has been available and affordable in recent 
years, genomic data increase rapidly as well, which leads a close related problem as sequencing 
data compression. The difference between genomic data archiving and sequencing data 
compression lies in the property of data, that is, in sequencing data compression, data is always 
short reads generated by shot-gun sequencing strategy, while the targets in genomic data archiving 
are different samples sequenced from same genome, e.g. different individuals or different 
experimental conditions.  Thus, the facts that the variation among genomes from multiple samples 
could be limited and the genomic data are long, assembled genome make reference-based 
framework a natural choice to approach the problem. 
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To summarize, these methods bear one or more advantages of the following: 1) 
compressing subfield of FASTQ file separately; 2) utilizing reference; 3) independence of available 
genomes and self-certainness. The idea of utilizing all these properties leads to our study of 
assembly-based compression tool. 
In this dissertation, we put forward a novel compression method for NGS data. This method 
utilizes an assembly-based framework, which is based on non-parametric philosophy, not only to 
avoid the limitation of heavy reliance on reference availability and quality, but also get rid of the 
hassle of version control of references.  
2.2 METHODS 
Our ultimate aim is to solve the challenge of sequencing data explosion in recent years. To start 
with, we proposed to develop a computational method, Assembly-based Sequencing Encoding 
Tool (AbSEnT), to compress large NGS data sets, which are stored as FASTQ format, into files 
that are smaller than the result of compression tools which are commonly used in the field 
nowadays.  
2.2.1 Framework of the genome-independent compression method AbSEnT 
To fully utilize the different statistical properties of the three fields, including read identifiers, read 
sequences and read quality in the FASTQ format, we encode them separately with different 
strategies. First, the read identifiers are encoded with dictionary coders. The read identifier field is 
usually composed of several subfields, storing experiment information like instrument names, run 
ids, flowcell ids and so on. These subfields are identical for each read entry in most case. Thus, to 
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reduce the required space for storage of read identifiers, we compile the identifiers into patterns 
that capture the structure of identifiers, and encode the variable subfields with arithmetic and delta 
coding algorithm.  
 
  
Figure 2: Compression and decompression schema for read sequences data. A) The raw sequences are first 
assembled to a virtual genome serving as reference using de Bruijn graph. All raw reads are mapped to the virtual 
genome. The aligned reads are further encoded as relative information to the reference, such as strand, read length, 
position on reference and difference between read and reference. The virtual genome, unaligned reads and relative 
information to the reference are then encoded with entropy compression models into a single file. B) The 
decompression schema is basically the reverse of compression.  
Then, the read sequences are encoded by assembly-based method (Figure 2A). The 
assembly-based method first assembles short reads into a reference assembly with de Bruijn 
assembly method. And then data differencing strategy is used, that is all reads will be mapped to 
the reference assembly. For the aligned reads, only positions on the reference and mismatches 
between reads and reference are recorded. These differences, the reference assembly as well as the 
unaligned reads are passed over to arithmetic coder separately for further compression. In this 
assembly-based method, the raw reads are expected to be closer to the reference assembly than to 
the curated genomes from public database, given the fact that the assembly is directly generated 
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from the specific data set. We found the assembly-based compression method is both effective and 
efficient on out test NGS datasets.   
The compression of read quality data is notorious since the pattern of the quality data are 
more random and hence harder to find than that of read sequences or identifiers. Thus, many tools 
are trying to use lossy compression on quality data. However, to keep compressed file faithfully to 
the raw data, we chose to compress quality data lossless. We used run-length algorithm and delta 
encoding to take advantage of local similarity property of quality data. Meanwhile, we investigated 
the positional entropy of quality data for possible improvement of compression ratio. Afterwards, 
arithmetic coder is used to achieve better efficiency. 
As the encoder is a lossless compressor and the encoded file is self-contained, the 
decompressor is coded to extract the encoded file and restore the original data file faithfully. The 
read labels are recovered by substitute words back into patterns, which are constructed in 
compression, and form original identifier entries. The read sequences are decoded by the stored 
positions on the reference assembly and the difference to the assembly using reverse strategy 
(Figure 2B).  The read quality values can also be restored straightforwardly by the information and 
models built in the compression process.  
2.2.2 de-Brujin graph build-up 
First of all, to convert sequences of nucleotides into a de-brujin graph representation, the sequence 
data was interpreted as overlapped k-mer with k = 32 nts and the adjacent 32-mer would be 
connected with a directed edge from former 32-mer to the latter one. Thus, take a sequence with 
length of 100 nts for example, it would be converted to a chain of 69 32-mer, and millions of such 
sequences would be converted to a de-brujin graph with millions of nodes and even more edges. 
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Hash map was used to represent the de-brujin graph in the lower level data structure in which each 
node stores the information of one unique 32-mer. In the node, the count of each unique 32-mer 
was recorded by incrementing 1 when each time it occurred, and the number would be used as the 
weight for each node in the following network pruning step. Besides, the weights of neigbour 
nodes were also stored for fast access. Each node is bound with the unique 32-mer where the 
sequence of 32-mer serves as key and the node struct serves as value in the key-value paradigm of 
hash map data structure. The connections between nodes are implicitly represented by shifting keys, 
which means trimming the first nucleotide of current key and appending any one nucleotide of A, 
C, G or T would make a key for the next node. 
2.2.3 Simplification and pruning of de-Brujin graph 
When a de-Brujin graph is built from a genome scale data set, the network would always be huge 
and hard to process and interpret, since the vast number of nodes, each of which stands for a unique 
fix-length word that appears in the data set, and edges, which stands for the relationship between 
these unique words. With such complex network in hand, how can we get useful information from 
there, say a reasonable assembly of short reads? Thus, it is crucial to develop a method to simplify 
the network and rule out unnecessary information from it. And the simpler the network, the easier 
and longer the genome can be read out, which increases the confidence of the assembled genome.   
A large set of simplification techniques can be applied to the de-brujin graph. The goals of 
them are always pruning out the irrelated reads and keep the network as simple as possible. Here in 
our research, there is an addition requirement, which is mapping as many reads as possible to the 
assembly, which is read directly from the network, so that more reads can be compressed in the 
encoded way. Thus we could not just prune nodes and edges out just by the structure of the 
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network, but also consider the weight of each node and edge, making the highly weighted nodes 
and edges survive in the pruning.  
The overall process is a cycle consisted of two steps, the pruning step and the contraction 
step. In the pruning step, different methods can be applied to the network to prune out unnecessary 
or less confindent information given the current network structure or weights of nodes, while in 
contraction step, the pruned network has to be simplified and restructured for the next step. The 
whole process stops until there is no node or edge can be pruned out or changed from the network. 
It is pretty like the classic process in EM algorithm. 
To complete the above process, another hash map was introduced in our data structure, 
which stores the contracted network of de-Brujin graph. In this data structure, each node would not 
represent one unique 32-mer and store the related information from it, but a long string that is 
contracted from a chain of nodes in de-Brujin graph and its information. The first 32 nucleotides 
would be used as the key of this node, and the value includes the string it stores, the total number 
of occurrences of all 32-mers it includes, pointers to the neighbor nodes and their counts of 
occurrences, the average coverage of this string from nodes in the previous de-Brujin graph, and 
additional information for data analysis and graph traversal. Again, the information of edge was 
stored implicitly within the two nodes it connected. We call the contracted network as dense graph. 
2.2.3.1 Branch zipper and Bubble zipper 
Under some cases, there would be some similar sequences with minor difference either from 
seqeuncing noise or biological mutation in the cell. These sequences would be stored in differnet 
nodes in the network. To make the assembled genome concise, we would like to combine these 
nodes together to remove the local similarity among sequences and save a version with more 
weight. Foutunately, because of the way de-Brujin graph and the dense map is built, these nodes 
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would be close in the network structure: either share the same ancestor or same decedant, which 
could be simplified with zipper algorithms.   
For branches in the network, we would first find the shared ancestor or decedant of the two 
branches and set it as an end-point. Then, we would compared the two branches to check whether 
they are similar by a simple alignment algorithm. If they are similar, we would merge the branch 
with lower coverage to the other, keep the merged branch and remove the other afterwards. The 
whole process is metaphored as zipper, because of the similarity.   
For bubbles in the network, there would be two end-points to detect and merge the pathes 
between these two end-points if they are similar with each other. The whole process is 
implemented with breadth-first search and basic seqeunce alignment algorithm. Similar to branch 
zipper, bubble zipper is, however, more complicate, since the bubbles could be tangled together as 
knit, forming a complicated thread to zip.   
2.2.3.2 Low importantance nodes filter 
Besides structure simplification, we pruned out low importance nodes each cycle when we 
got a simplified dense graph. Which are low importance nodes? Here we judged by the averge 
coverage index, which is calculated by dividing the weights of the nodes by difference of the length 
of the string that the nodes represent minus 31. We could imagine a node with low coverage could 
have a high possibility been generated from background noise. And even the sequence was with 
real meaning, e.g. from low frequent RNA products, it would not benefit compression, since the 
repeatence is so low. We could see that lots of sequence located in this part in the result section. 
The cutoff could be set to arbitrary value, as each data set could be different, but the sweet point is 
where the balance between over-pruning and under-pruning. Over-pruning would break the 
structure of network, making the assembled genome short and fragmented, while under-pruning 
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would make the read-out of network hard, as the structure of the network was not reasonably 
simplified.  
After the whole process converges, the whole dense graph would be read out by breaking 
down in the ambiguous nodes, which is defined as the crossring of two paths in the graph, so that 
the graph can be converted to a set of chains of nodes. The strings stored in each chain would be 
concatenated together and saved as one assembled chromesome in the assembled genome.  
2.2.4 Mapping and encoding of the Sequences 
After the assembly is created, we mapped all reads from the original sequencing data set to the 
assembly with bowtie. The mapping result file is processed by a python script to reorganize the 
mapping information. For example, if a read can be fully mapped to the genome, then the mapped 
chromosome, the position on the chromosome would be recorded. If the length of sequence in the 
data set is not same for all, the length of the sequence would also be saved after python processing, 
otherwise, a global value of sequence length would be set in the result.  
When a read can be mapped to the assembly genome with minor difference, the difference would 
also be recorded, such as the position of mismatch, the kind of mismatch, like mismatch, insertion 
and deletion, and the portion of subsequence of the mismatch, so that the read could recovered in 
the decoding process. When a read cannot be mapped to the assembly genome, they would be 
saved to a separate file. The three files, one that saves difference information of mappable reads, 
one that records the unmappable reads, and one that includes the assembled genome, would be 
processed by statistical encoding tool to a binary compressed package in the following step, which 
can be stored, shared and delivered with efficiency.    
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2.2.5 Decoding of the sequences 
The decoding process is basically the reverse step of encoding. Since the whole process is lossless, 
all information is contained in the compressed binary package. The package is first decoded by 
statistical tool, and then the three files it contains would be utilized to recover all raw reads from 
the original sequencing data set.  
2.3 RESULTS 
2.3.1 Redundancy of information in sequencing dataset 
To illustrate the redundancy in sequencing datasets, we investigated the distribution of frequency 
of unique subsequence (word) with 32-base long. We divided long sequence of reads into 
overlapped 32-base words, that is, two adjacent words overlap by 31 bases; and further, we 
calculated the frequency of each unique 32-base word.  Then we binned all words by the 
occurrences in the dataset and counted the total occurrences of each bin. We further plotted the data 
in Figure 3, in which the bins are plotted as x-axis and the total occurrences of each bin as y-axis in 
log-log scale.  
In the log-log plot, we can find that the distribution asymptotically converges to a straight 
line, which may indicates the distribution follows the power law distribution. The graphical 
illustration of the power law distribution can be straightforward by plotting a log-log plot, but a 
strict validation of whether a distribution follows power law is difficult and we did not perform this 
test right now. Although we canno not validate the power law property, this graph reminds us 
Zipf’s law, which is a widely-used empirical law in linguistics analysis, stating that given a large 
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and structured set of uninterrupted text, the frequency of any word is inversely proportional to its 
rank in the frequency table. It is also closely related to discrete power law probability distribution. 
In the case of unique fix-length words in sequencing data, the relationship between the occurrence 
of each unique word in a dataset and the number of unique words with same occurrence also 
follows an inversely proportion relationship and might follows the power law. 
 
 
Figure 3. The distribution of word frequency in sequencing data sets. A-B) Dataset ERR030867 and Dataset 
ERR030894, respectively. In the log-log plot, a straight line declining pattern might indicate a power law distribution 
of word frequency. C) Dataset SRR359032. A wavy curve in the log-log plot does not indicate a power law 
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distribution. But if it varies around the presumed straight line, the answer might be different. 
 
 
 
Figure 4. Galley of dense graphs after pruning and simplication. Top-left graph is one sample subgraph after graph 
simplication. There are some loops and bubbles in the subgraph which could not be removed in the pruning step. The 
subgraph could also be as simple as a linear or circular chromosome, like the top right subgraph; or it could still be 
hard to read out, e.g. the center part of the bottom subgraph.  
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2.3.2 de-Brujin Graph pruning and simplification 
After several rounds of pruning and simplification of de-Brujin graph and dense map through 
various filters, such as lower importance filter and different zippers, the network can be simplified 
from unreadable complex network to hundres of realative simpler and smaller subgraphs (Figure 
4). Each subgraph would be read out by breaking the graph into paths and each path with enough 
coverage and length is treated as a chromosome in the assembled genome.  
2.3.3 Compression efficiency of AbSEnT 
To show the efficiency of assembly-based compression method, we used a whole genome 
sequencing dataset of Pseudomonas Syringae as an example. To build a reference, we first 
assembled a genome from all raw reads in the data set with de Bruijn graph method that mentioned 
in previous section. The assembly of all reads is of length 14,924,049 nucleotides. Out of all 
3,551,133 raw reads, ~93.5% of them can be mapped back to the reference assembly, indicating the 
high quality of the assembly. To test the compression efficiency of our method, we extracted all 
read sequences, which is of size 131,391,921 bytes, from the original data. With general-purpose 
compressor bzip2, the compressed file is of size 37,616,023 bytes, the compression ratio of which 
is 2.290 bits/nt. With our assembly-based method, the compressed file size is 10,143,007 bytes, 
which is less than one third of bzip2 file and of compression ratio of 0.618 bits/nt. More in detail, 
the compressed file is comprised of three parts, which are encoded assembled genome, mapped 
reads and unmapped reads. In this particular dataset, the encoded reference assembly is of size 
3,993,063 bytes; the size of encoded mapped reads is 3,081,001 bytes; the remaining ~6.5% 
unmapped reads takes 3,068,943 bytes which is about one third of total size of the compressed file. 
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These statistics reveal us that mapped reads can be encoded much more efficiently than unmapped 
reads.  
Table 1. Bzip2 and AbSEnT compression statistics on Pseudomonas Syringae whole genome sequencing data. 
 Bzip2 AbSEnT 
Raw data 131,391,921 bytes 131,391,921 bytes 
Virtual genome  - 14,924,049 bytes 
Compressed virtual genome - 3,993,063 bytes 
Percentage of mapped reads - 93.53% 
Compressed mapped reads  - 3,081,001 bytes 
Compressed unmapped reads - 3,068,943 bytes 
Compressed data 37,616,023 bytes 10,143,007 bytes 
Compression ratio 28.6% 7.7% 
2.4 DISCUSSION 
2.4.1 Evaluation of compression algorithm  
To evaluate a compression algorithm, several aspects should be considered. The first and 
the obvious one is the compression ratio, which is the purpose and goal of compression algorithm. 
However, the compression ratio is not the only criteria that matters. To make a compression 
algorithm feasible, one important factor to be considered is the speed of both compression and 
decompression. The scalability is also one merit that a good compression algorithm should have. 
Both of them might have a direct impact on the utilization of the algorithms.  
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The bottleneck of assembly-based compression method is the efficiency of de-novo 
assembly. As we do not need a curated-level genome, the efficiency can be largely increased by 
slightly losing the accuracy of the reference assembly, as long as it accommodates a high portion of 
all raw reads. Moreover, a statistical de-Bruijin method can also be incorporated into the tool to 
improve the efficiency and scalability of the assembly algorithm.    
The evaluation data set should be comprised with multiple next-generation sequencing data 
sets from different application of NGS, including whole genome sequencing, exome sequencing, 
ChIP-seq, RNA-seq, and metagenomic DNA sequencing. The performance of AbSEnT as well as 
other available tools, including gzip, bzip2, 7z, DSRC, G-SQZ and Quip, should be evaluated on 
all categories in terms of compression ratio and speed to illustrate the feasibility and efficiency of 
AbSEnT and make comparison with other tools.  
2.4.2 Lossless compression and lossy compression 
In addition to the lossless compression we mentioned above, we might also perform data 
compression in a lossy way. Again, let us take image compression for example. People has a detect 
limitation when an image is shown as our eyes can hardly discriminize subtle difference of small 
pixels. Therefore, a small variation of the color or grayscale of a small number of pixels might just 
merely change our interpretation of the image at most, but would benefit a lot for compression 
algorithms, since the outliers always take a large of mount of information in the compressed dataset. 
Also, for each image, we concentrate on the subject we are interested in or the theme that was 
designed to deliver by the image but overlook the background information there. Thus, in some 
lossy image compression algorithm, the valuable space in bits would be allocated more to the main 
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subject of the image or the region of interest and less for less informative region, so that a higher 
compression ratio can be achieved without losing too much information and quality of the image. 
Similar to the image compression, bit allocation concept could also be utilized in the 
compression of sequencing data. One of the advantages of sequencing data compression comparing 
to image compression lies in the fact that there is a quality field in the sequencing data, which 
naturally confines the region of interest. In image compression, algorithms designers have to design 
a smart method that the algorithm can find the region of interest by it self, which is not always 
handy. In contrast, although one might argue that the regions that constrained by sequence quality 
data might not be the regions of research interest, the quality field gives researchers the region 
where the sequencing data can be trusted or not, which provides researchers an easy option to 
allocate more bits to the trusted region instead of a uniform allocation. In this way, the information 
of the sequencing experiment would mostly be reserved and it can be squeezed with high efficiency, 
as the data of untrusted region are more likely to be unrelated or unstructured noise and thus harder 
to be compressed, which seems to be a balanced tradeoff between storage space and scientific truth.  
It is interesting to discuss the tradeoff between the lost of information and the gain of space 
saving in lossy compression. Is it worth to loss the valuable information that we get from the 
expensive experiment but gain some more, e.g. 20%, space saving in the compressed data? No 
concensus answer can be achieved among scientists easily until lots of contrast experiments are 
performed and many arguments are considered. However, insprired by the image compression, we 
found that not all information of the raw data, no matter it is images or sequencing data, would be 
utilized in the downstream analysis. Specifically speaking of sequencing data, the sequences with 
low quality would probably be filtered out by preprocessing procedure for quality control, making 
these data not necessary to be stored in the compressed data set. Then, a new question comes up: 
what is the best cutoff of quality to store the meaningful data? The answer is still unsettled and 
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need time for scientists to determine. But in fact, the cutoff really depends on the property of the 
data set and what the data set is designed for. For example, if the data set is designed to discover 
some rare sequences in the cell, the cutoff might be set to a lower one so that to keep these rare 
seuqnces from filtering out because of random noise. In terms of compression, we might set 
multiple cutoffs for the quality and compress the data set separately for different purposes.  
2.5 SUMMARY 
We release an assembly-based sequencing compression tool, AbSEnT, that contains compressor 
and the corresponding decompressor to process FASTQ files. The compressed files generated by 
this tool are not only lossless and self-contained to free the storage and manpower needed to 
maintain a set of reference genomes, but also with a higher compression ratio than general-purpose 
compression tools. The tool efficiently and effectively lowers the demand of storage of massive 
sequencing datasets and reduces the time for sharing the datasets among collaborating labs and 
groups. With these merits, we expect this tool would be broadly useful for the biological scientists, 
especially who work on next-generation sequencing intensively. Moreover, we discover the 
distribution of words frequency in sequencing data set shares a similar pattern with books and 
social network. We expect to improve our understanding of these statistical properties of different 
sequencing data sets in the course of pursuing higher compression ratio. We have also discussed 
the evaluation of compression method from various aspects. We expect to improve the efficiency 
of AbSEnT and optimize the speed of encoding and decoding.   
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3.0  BUILDING COMPREHENSIVE POLYADENYLATION MAP OF HUMAN 
GENOME 
3.1 INTRODUCTION 
We present a comprehensive map of over 1 million polyadenylation sites and quantify their usage 
in major cancers and tumor cell lines using direct RNA sequencing. We built the Expression and 
Polyadenylation Database to enable the visualization of the polyadenylation maps in various 
cancers and to facilitate the discovery of novel genes and gene isoforms that are potentially 
important to tumorigenesis. Analyses of polyadenylation sites indicate that a large fraction (∼30%) 
of mRNAs contain alternative polyadenylation sites in their 3′ untranslated regions, independent of 
the cell type. The shortest 3′ untranslated region isoforms are preferentially upregulated in cancer 
tissues, genome-wide. Candidate targets of alternative polyadenylation-mediated upregulation of 
short isoforms include POLR2K, and signaling cascades of cell–cell and cell–extracellular matrix 
contact, particularly involving regulators of Rho GTPases. Polyadenylation maps also helped to 
improve 3′ untranslated region annotations and identify candidate regulatory marks such as 
sequence motifs, H3K36Me3 and Pabpc1 that are isoform dependent and occur in a position-
specific manner. Moreover, thousands of novel polyadenylated sites were found both in 3' UTR 
and intergenic regions, out of which a large number (~1000) of sites show a consistent up/down-
regulation in majority of tissues tested. In summary, these results highlight the need to go beyond 
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monitoring only the cumulative transcript levels for a gene, to separately analysing the expression 
of its RNA isoforms. 
3.1.1 Alternative polyadenylation 
Alterations in 3′ untranslated regions (UTRs) that drive post-transcriptional control of gene 
expression is a common theme in multiple diseases including cancer23,24,25. Recent reports also 
provide surprising and compelling evidence that in proliferating/cancer cells, genes often switch 
their expression toward the short 3′ UTR isoforms that correspond to truncated versions of the 
canonical long isoforms26,27. However, 3′ UTR isoforms are poorly annotated in databases28 
because common high-throughput technologies such as microarrays, RNA-Seq and quantitative 
reverse transcriptase-polymerase chain reaction cannot readily distinguish between 3′ UTR 
isoforms. This limitation arises because the long 3′ UTR isoforms encompass the short isoforms, 
and therefore the short isoform-specific probes/primers hybridize to both short and long isoforms, 
leading to inseparable, mixed signals27,29. Such limitations in precisely identifying and quantifying 
3′ UTR variants can lead to erroneous conclusions in not only gene expression studies but also in 
investigations of posttranscriptional events26,27. New approaches such as Direct RNA sequencing or 
DRS30, 3P-Seq28, PAS-Seq31 and others32,33 are beginning to be adopted to identify 3′ UTR 
variants, allowing the construction of a near-complete map of 3′ UTR variants of the human 
genome31,34.  
Polyadenylation can generate many alternative transcripts of a given gene, with important 
consequences. Alternative polyadenylation (APA) can lead to truncated protein isoforms, abrogate 
protein-coding capacity, affect transcript stability, alter translation efficiency and affect transcript 
export35. Important oncogenes such as p53 and CCND1 are known to have altered polyadenylation 
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that results from simple 3′ UTR mutations36,37. A related emerging theme in cancer biology is that 
APA within the same 3′ UTR can enhance production of oncogenes27 because shorter 3′ UTR 
isoforms have higher translational efficiency than their respective long isoforms. Although APA 
within the same 3′ UTR simply results in mRNA isoforms that code for identical proteins, it can 
alter miRNA targeting regions27, subcellular localizations and stability38, and protein production 
rate35. Thus, tandem APA seems to provide an alternative mechanism to complement more subtle 
posttranscriptional regulatory modes such as miRNAs that can cause either translational arrest39 or 
destabilize target RNAs40,41 in human cells42. The existence of a mechanism that preferentially 
alters the relative expression ratio of long and short isoforms is also observed in embryonic 
cells31,43. The diversity of transcripts produced via polyadenylation and its consequences 
underscore the need to accurately catalog and study polyadenylation in both normal and diseased 
cells.  
3.1.2 Genome-wide Polyadenylation map 
We sought to build a comprehensive polyadenylation map of the human genome across major 
cancers and their cognate normal tissues, which could also facilitate studies on 3′ UTR isoforms, 
and enable discoveries of important novel gene isoforms. To reduce artifacts associated with 
common deep sequencing strategies, we used DRS to construct the polyadenylation landscape and 
measure gene expression directly without manipulating purified RNA (308). We built a public 
resource for tissue-specific polyadenylation sites termed Expression and PolyAdenylation Database 
(xPAD), which represents a comprehensive analysis and discovery platform for the investigation of 
more than 1 million polyadenylation sites, 3′ UTRs and their cellular usage, across five major 
organs, their cognate tumor samples, and six different cell types including commonly used 
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ENCODE44 cell types (Hela-S3, HepG2, K562 and MCF7). Approximately 9000 polyadenylation 
sites are well expressed (≥10 reads) and are at least 1000 nucleotides (nts) away from annotated 
gene regions, indicating the presence of many novel polyadenylated gene isoforms and genes. DRS 
reads also reveal potential polyadenylation in many non-coding RNAs including the lncRNA45, 
GAS5 that encodes 10 snoRNAs, which are all unexpectedly polyadenylated. The simultaneous 
determination of gene isoforms and their levels also opens up additional opportunities in exploring 
the data, such as using network and motif analysis for studying gene isoforms. Indeed, network 
analysis of genes that manifest APA suggest that cell–cell and cell–extracellular matrix (ECM) 
contact mediated signaling cascades are potentially key targets of APA in cancer, particularly 
involving regulators of Rho family small GTPases that are consistently targeted by these 
mechanisms across the samples tested. The nucleotide level resolution of the polyadenylation maps 
also enabled the discovery of novel sequence motifs and regulatory marks (e.g. H3K36Me3) that 
are highly position specific with respect to polyadenylation sites and are isoform dependent. In 
summary, the polyadenylation site maps and its usage reported here reveal an extensive landscape 
of both known and novel polyadenylated genes, their isoforms, and their regulation.  
3.2 MATERIALS AND METHODS 
3.2.1 DRS sequencing and genome mapping 
Matched pair (normal/tumor) total RNA from tissues was used for DRS30,34; all paired RNA 
samples for sequencing were purchased from Biochain (Hayward, CA), except for Breast 
(Asterand, MI). Raw DRS reads were quality filtered using HeliSphere 
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(http://open.helicosbio.com) and in-house tools  to remove low-quality sequences and reads shorter 
than 25 nts. The filtered reads were mapped to the human genome (GRCh37) with maximum 
allowed error of 10% (mismatches and indels) by MOSAIK46 with conservative parameters (-mmp 
0.1 -mhp 100 -act 20 -hs 15 -p 8 -bw 13). Although internal priming in DRS data is negligible, we 
implemented filters for quality control, following a more stringent criterion than the recommended 
removal of sequences with a stretch of eight consecutive adenosines47. For quality control, uniquely 
mapped reads were further filtered to remove all sequences that genomically contained either six 
consecutive Adenosines or at least seven Adenosines within 10 nts downstream of the end of the 
mapped DRS reads.  
The mapped locations were annotated using the UCSC genome browser tables48. When a 
locus could be attributed to multiple possible annotations, the locus was assigned with a single 
annotation in the following priority order: 3′ UTRs (sense), coding sequences (CDS, sense), 5′ 
UTRs (sense), intron (sense), non-coding RNAs (ncRNAs, sense), 5′ UTR antisense, CDS 
antisense, 3′ UTR antisense, intron antisense, promoter antisense, ncRNA antisense and intergenic. 
Unlike other regions, intergenic regions are not separated into sense and antisense strands. 
Promoter regions were defined as regions 1000 nts upstream of transcription start sites provided by 
UCSC genome browser tables. DRS reads mapping to regions that are at least 5000 nts away from 
the closest gene region (sense/antisense) were annotated as intergenic.  
Because polyadenylation sites vary by a few nucleotides in a given isoform, we used the 
snow-ball method to define polyadenylation sites49. The snow-ball method iteratively clusters 
genomic locations that are located within 24 nts, using the genomically mapped 5′ positions of the 
DRS reads as a reference. For analysis of genes containing tandem polyadenylation sites, 
polyadenylation sites with less than 10 total reads in the combined set of normal and tumor reads, 
were removed. The proximal polyadenylation site was defined as the first polyadenylation site after 
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the end of the CDS on the 3′ UTR. The distal polyadenylation site was defined as the last 
polyadenylation site after the end of CDS on the 3′ UTR. If a gene contains more than two tandem 
polyadenylation sites on the 3′ UTR, only the first and last sites are used for analysis27. To account 
for variations in sample loading, the number of reads from each polyadenylation site was 
standardized to contain an equal number of reads across all tissues, using the normal breast tissue 
reads as a reference. To enable more accurate comparisons, the resulting expression levels were 
further quantile-normalized (R package) between normal and tumor within each tissue. To analyse 
whether quantile normalizations of the samples are justified, Quantile–quantile plots of raw read 
numbers (log2 scale) between tumor and normal samples were analysed, which yielded high 
correlation (R =  0.98−0.99) along the diagonal. The distance between adjacent polyadenylation 
sites were defined as the distance between their 5′ most cleavage sites. To determine variances in 
polyadenylation site locations, the mean location of each polyadenylation cluster (≥10 reads) was 
determined. For a given cluster, polyadenylation sites corresponding to every read was used to 
determine the mean location of the polyadenylation site. For each polyadenylation site cluster, the 
distance between the polyadenylation site of each read and the mean location was used to calculate 
variance.  
3.2.2 Sequencing data preprocessing with in-house tool 
In sequencing data analysis, data preprocessing is important step in the whole pipeline, since in 
large sequencing data sets, there are a lot kinds of noises coming from various sources, which 
include but not limited to sequencing machine’s system errors, noise from samples which may 
come from different labs with a more or less different experiment conditions and imperfections of 
various sequencing techniques. These noises could lead to serious results in the statistical analysis 
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and might further impact on the interpretation of the data, leading. Also date sets of next generation 
sequencing are high-throughput which is prone to be sensitive to background noise, resulting in a 
relative low ratio of signal and noise (SNR). Thus, a careful noise filtering before the analysis 
routine is crucial for the result of each successful experiment.  
In the analysis of polyadenylation sites in various cell lines and tissues, we utilized Helicos 
next generation sequencing techniques for sites detection. Due to the fact that Helicos’s technology 
has a relative higher error rate compared to other mainstream NGS techniques, we would put more 
attention on data preprocessing to filter out reads from background noise.  To help retain only high 
quality reads, in addition to Helisphere software, we used in-house tools to remove additional reads 
that occur due to imperfections in surface that results in reads that resemble the sequence of 
sequencing reactions, resulting in perfect or imperfect repeats of AGCT. Although Helisphere 
software already eliminates such reads, we have observed using other data sets that the use of the 
method outlined below can be helpful. For each read, we determined the extent of divergence from 
the repeating sequence of AGCT; Kullback–Leibler (KL) divergence measure (MATLAB) was 
used based on the two different frequency distributions (P,Q) of tri-nucleotides of the read (P) and 
that of the repeat sequence of AGCT [Q(i) =0.25 for i = AGC/GCT/CTA/TAG; Q(i) =0 otherwise] 
KL score was defined as  , where  represents one of the 64 possible tri-
nucleotides. In this setting, a biased read with high AGCT repeat would have a lower KL score, 
while an unbiased read from polyadenylation site would generally have higher KL score. Only 
reads above a KL divergence threshold of 40 was considered for further filtering; threshold was 
determined by tests on randomly generated sequence datasets, which on average retained ~90% of 
reads at the threshold of 40 (Figure 5). The reads were then further filtered using genome mapping, 
as described afterwards.  
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Figure 5: The histogram of KL-divergence of a set of random generated sequences. The KL-divergence between 
each random sequence and the repeat sequence of AGCT is calculated individually and then the distribution of this 
statistic is plotted as a histogram. We can see from the histogram, ~90% of the sequences have a KL-divergence higher 
than 40, which is used as a threshold for the high quality reads filter.  
3.2.3 Determination of usage of short and long 3’ UTR isoforms  
For genes with more than one tandem polyadenylation site, Short and Long represents the total 
number of reads (quantile normalized) from the proximal and distal polyadenylation sites, 
respectively. To compare the relative usage of the distal polyadenylation site between normal and 
tumor tissues, we used the previously reported RUD indices (RUD = log2[Long/Short]; ∆RUD= 
RUDtumor−RUDnormal). RUD is used in the strict sense of its definition; manipulations to emulate 
mixed signals from short isoforms in parent studies that used RUD were avoided for sake of 
simplicity, particularly since our conclusions were consistent with previous studies. For example, 
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∆RUD ≥ 1, corresponds to at least two-fold increase in Long/Short ratio in tumor, and hence 
represents those genes that favor the expression of their long isoforms in tumor. To determine 
differences in expression levels of either short (∆Short) or long (∆Long) isoform levels between 
normal and tumor tissues, we computed the log2-transformed fold-change ratio 
(∆LogShort=log[Shorttumor/Shortnormal]; ∆LogLong=log[Longtumor/Longnormal]).  
3.2.4 Motif-enrichment analysis 
The total number of genes used for motif-enrichment analysis is identical for both short and long 
isoforms. Because some of the polyadenylation sites are tissue-dependent, motif analysis was 
constrained to short and long isoforms detected in a single tissue-type (normal breast). To ensure 
that the polyadenylation sites of short and long isoforms are well separated, we further constrained 
the analysis to those sites that are at least 100 nts apart, resulting in a total of 3270 genes. Motifs in 
regions flanking (±500 nts) the polyadenylation sites of the short and the long isoforms were 
detected based on the DREME50 motif discovery algorithm, followed by a statistical assessment 
(E < 0.05) of the positional preference of the motifs, using CentriMo51, a position-specific motif-
enrichment analysis method. The analysis resulted in a total of 27 motifs, six of which were 
eliminated because they occur in a limited number of sequences, corresponding to less than 5% of 
the sequences at those distinguishing positions that are most enriched for the motifs. To focus on 
isoform-dependent motifs, the observed preference of each motif was further tested by the 
bootstrapping approach to determine statistical significance, and a final non-redundant set of eight 
motifs were selected using default parameters of TOMTOM52. 
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3.2.5 Statistical tests 
Both the Ansari–Bradley and F tests were used to test whether the variances in locations of 
polyadenylation-sites in short and long isoforms are statistically different (MATLAB). As F-tests 
yielded more statistically significant numbers, we report only the P values obtained using the most 
conservative test (one-tailed Ansari–Bradley). For testing the observed increase/decrease in tumor 
cells for the absolute or relative expression of short and long isoforms, the non-parametric one 
tailed Wilcoxon signed rank test was used. Bootstrapping analysis for motif detection was 
performed by randomly sampling (with replacement, n = 3270), the complete set of either short or 
long isoforms to yield 10 different datasets for each isoform. The resulting distribution of 
occurrences for each motif at their characteristic location in each of the 10 datasets were calculated 
for both short and long isoforms, and compared using two-tailed student t test.  
3.3 RESULTS 
Polyadenylation can generate many alternative transcripts with important consequences. 
Alternative polyadenylation (APA) can lead to truncated protein isoforms, annul protein-coding 
capacity, affect transcript stability, alter translation efficiency, and transcript export35. An emerging 
theme in cancer biology is that APA within the same 3' untranslated region (UTR) can enhance 
production of oncogenes27 because shorter 3' UTR isoforms have higher translational efficiency 
than their respective long isoforms. Although APA within the same 3' UTR simply results in 
mRNA isoforms that code for identical proteins, it can alter miRNA targeting regions27, subcellular 
localizations and stability38, and protein production rate35. Thus, 3' UTR APA seem to provide an 
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alternative mechanism to complement more subtle post-transcriptional regulatory modes such as 
miRNAs that can cause either translational arrest39 or destabilize target RNAs40,41 in human cells42. 
The existence of a mechanism that preferentially alters the relative expression ratio of long and 
short isoforms is also observed in embryonic cells31,43. The diversity of transcripts produced via 
polyadenylation underscore the need to accurately catalog and study polyadenylation in both 
normal and diseased cells. 
3.3.1 Genomic feature of polyadenylation sites  
Five matched pairs of tumor and normal tissues from human breast, colon, kidney, liver and lung 
and six commonly used cell lines, including Hela-s3, Hepg2, K562, LNCaP, MCF7 and PC3, were 
 
Figure 6: Characteristics of polyadenylation sites. DRS reads from normal breast tissue are used for this 
illustration. A) Cleavage sites of short isoforms in either normal (Normal Short) or tumor (Tumor Short), are 
generally (9/10) more variant than that of the corresponding long isoforms (p-values on top). B) In breast, the majority 
(~90%) of DRS reads match to sense strands of transcriptionally active regions and the remaining reads mainly map to 
intergenic regions and introns. For illustration purposes intergenic polyadenylation sites are assigned to the sense 
strand because categorizing them into sense and antisense strands separately can be ambiguous. C) Polyadenylation 
density in internal introns is higher than that of terminal (5' and 3') introns for both sense and antisense intronic 
transcripts.  
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used to obtain DRS30,34 reads using the Helicos Sequencer. Both normal and tumor tissue samples 
yielded comparable number of reads. Moreover, the total number of genes that were expressed in a 
given cancer type (≥ 10 reads) and contained tandem polyadenylation sites were approximately the 
same across organs. Consistent with previous reports, we find that although polyadenylation sites 
frequently vary53,54 the average absolute deviation based on all distinct locations within a cleavage 
site cluster is small (±2.7 nts), indicating that cleavage is highly precise. Intriguingly, perhaps due 
to differences in the factors that govern the cleavage of the short and long isoforms, short isoforms 
manifest a statistically significant higher variance for cleavage sites than long isoforms, across all 
tissues (Figure 6A). 
In normal breast tissue, the majority (73-90%) of the reads mapped to the sense strands 
(Figure 6B) of functionally important regions (3'/5' UTR, coding sequence i.e. CDS, intron, non-
coding RNA i.e. ncRNA, and promoter). The observation that sense transcripts constitute the major 
fraction (~70%) of polyadenylated total RNA is fully in agreement with other studies55,56. Notably, 
anti-sense transcripts are enriched in intronic regions across all 10 tissue types. Although most of 
these antisense transcripts are not abundant, ~17% of these transcripts occur in clusters separated 
by less than 2500 nts, suggestive of transcription and subsequent polyadenylation of antisense 
transcripts in intronic regions. Further analysis revealed that in comparison with terminal (5' or 3') 
introns, internal introns are significantly more enriched in both sense and antisense polyadenylated 
transcripts (Figure 6C). The enrichment is consistently stronger for intronic sense transcripts than 
antisense transcripts. Although the polyadenylation site density in antisense internal intronic 
regions is lower than that of the sense strand, it is always higher than that of terminal introns. The 
observed biases in intronic polyadenylation might be related to nucleosome depletion at internal 
introns57 that may be more susceptible to aberrant intragenic transcription58. The database xPAD is 
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built on these data and can be accessed through the web portal (Figure 10). 
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Figure 7: Overall properties of polyadenylation sites are consistent across tissues. A) Approximately 30% of genes 
contain tandem APA sites. B) Distribution of distances between adjacent tandem polyadenylation sites in the 3' UTR of 
genes expressed (bin size=50 nts). Adjacent pA sites that are separated by at least 5000 nts correspond to a small 
fraction (0.9-1.1%).  
Because tandem APA-mediated gene regulation that occurs without a change in the cognate 
protein sequence 59) is an emerging theme in cancer progression26,27,60,61, we investigated whether 
polyadenylated 3′ UTR isoforms are commonly produced. Approximately 30% of genes have 
multiple tandem polyadenylation sites in their 3′ UTRs in any given tissue (Figure 7A). Most of 
these genes have precisely two polyadenylation sites. The observed proportion is nearly identical to 
the previously reported percentage of ∼34%, determined using EST mapping49. Similarly, in 
accordance with the EST-mapping study, for those genes with multiple tandem polyadenylation 
sites, the adjacent polyadenylation sites peak ∼100 nts apart (Figure 7B) and have a median of 368 
nts. Thus, the overall genomic characteristics of polyadenylation events captured by both DRS and 
ESTs are nearly identical. 
3.3.2 Polyadenylation patterns of non-coding and novel genes  
Non-coding RNAs such as miRNAs and lncRNAs45 are frequently implicated in cancer 
progression62 and in some cases are known to undergo polyadenylation63,64. We analyzed whether 
miRNA and lncRNA regions are polyadenylated and if so whether those polyadenylated forms are 
aberrantly expressed in cancer. A modest proportion (12.3%) of the 14,403 lncRNAs locations is 
polyadenylated within 100 nts of their annotated 3' ends. However, most of these polyadenylated 
locations are not abundant, as only a small fraction (1.7%; 244 loci) of the lncRNAs generates 
many (≥ 10) reads in at least one of the 10 tissue samples tested. Abundantly polyadenylated 
lncRNAs loci include the well-known breast cancer metastasis-associated HOTAIR63 that is highly 
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(>12 fold) upregulated in breast tumor (49 versus. 4 reads). Although polyadenylated lncRNAs do 
not manifest a consistent pattern of differential expression across the majority of the tumors tested, 
the GAS5 and TMEM191A are two good examples of polyadenylated lncRNA regions that are 
aberrantly regulated in the majority of tumors tested (Figure 8A and B). The 4 kb long GAS5 that 
hosts 10 snoRNAs is frequently down-regulated gene in breast cancer65. In DRS results, GAS5 is 
also 3-fold down-regulated in breast tumor. Notably, although only 36% of snoRNAs are 
polyadenylated in at least one of the tissues, all GAS5 snoRNA loci are usually polyadenylated in 
multiple tissues, generally within ~5 nts of their annotated 3' ends.  
 
Figure 8: Genomic view of polyadenylated non-coding RNAs and novel gene locations that are aberrantly 
expressed in cancer using xPAD.  A-D) All polyadenylation sites detected by DRS reads (green: normal; red: tumor) 
are indicated for all four gene regions. A-B) GAS5 (A) and TMEM191A (B) represent lncRNAs that are upregulated in 
the majority of tumor samples, as indicated. In contrast to the polycistronic GAS5 which hosts multiple polyadenylated 
snoRNAs, polyadenylation of TMEM191A is limited to its 3' UTR. C-D) End locations and the expression levels of 
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We next investigated the presence of novel polyadenylated genes that may be important for 
cancer development or progression. To identify such novel RNA transcripts, we first probed for 
novel polyadenylation locations that are within annotated 3' UTR regions, are abundant (≥ 10 
reads) and are consistently either upregulated or downregulated in the majority of tissues. A total of 
19275 polyadenylated sites were identified, of which 842 were upregulated and 94 were 
downregulated in the majority (≥ 3) of the tumor samples at more than 2-fold levels, two of which 
are shown (Figure 8E and F). Further, we probed for novel polyadenylation locations that are at 
least 1 kb away from any known gene with the other criteria the same as the previous. A total of 
9612 potentially novel polyadenylated genes were identified, of which 77 were upregulated and 41 
were downregulated in the majority (≥ 3) of the tumor samples at more than 2-fold levels. The 
DRS results on the differential expression of two of these locations were also confirmed by real-
time reverse transcriptase-polymerase chain reaction (Figure 8C and D) which is experimented by 
Dr. Teresa Liu. These results underscore the notion that many additional RNAs and RNA-isoforms 
important for cancer and possibly for other diseases exist and that visualization tools for deep 
sequencing data could be useful in identifying such genes. 
two potentially differentially regulated novel genes that are distantly located from known genes. Real-time PCR results 
also reveal similar expression patterns (fold change) in two additional, matched-pair patient samples (p<0.001); error 
bars represent standard deviation (n=3). E-F) End locations and the expression levels of two potentially differentially 
regulated novel polyadenylation sites that are located in 3' UTR. 
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3.3.3  Polyadenylation sites contain isoform-dependent regulatory marks 
We sought to identify proteins that may differentially regulate short and long isoforms. Based on a 
large number (708) of publically available ENCODE ChIP-Seq or RIP-Seq data sets of 
transcription factors, histones and RNA binding proteins, we found that the histone mark, 
H3K36Me3 is consistently more enriched at short isoform polyadenylation site locations than that 
 
Figure 9: Polyadenylation maps enable the identification of isoform-dependent regulatory marks. A-D) A total 
of 3,270 genes containing both long and short forms that are genomically separated by at least 100 nts at their 3' ends 
are used for the analysis. Chip-Seq/RIP-Seq data comparisons of H3K36Me3 and Pabpc1 to their functional analogs 
(Pol2 and Elav1) in identical cell lines (B: HepG2, C: HelaS3, D, E: GM12878) suggest preferential marking of 
polyadenylation sites of short isoforms by H3K36Me3 and Pabpc1. The curves corresponds to the distance 
distribution between the location of a given polyadenylation site and the nearest regulatory mark, as inferred using 
Chip-Seq/RIP-Seq. 
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of long isoforms in all 42 datasets tested. In contrast, Pol2 occupancies at polyadenylation sites of 
long isoforms in the corresponding cell lines are higher than that of short isoforms (Figure 9A, B, 
C). ENCODE RIP-Seq data analysis revealed that polyA-binding protein 1, Pabpc1 (Figure 9D), 
could be another candidate that preferentially associates with polyadenylation sites of short-
isoforms. To ensure that the observed preference is not due to the mRNA binding ability of 
Pabpc1, the Pabpc1 profile was compared with that of a related mRNA binding protein Elav180, 
performed using identical conditions. The comparisons reveal that the Pabpc1 is more 
preferentially enriched at short isoform locations, suggesting that Pabpc1 likely has a role in 
regulating the polyadenylation sites of short isoforms (Figure 9D). In conclusion, multiple 
regulatory marks that correspond to both transcriptional and post-transcriptional regulatory 
complexes are present at locations proximal to polyadenylation sites in an isoform-dependent 
manner, indicating the interplay between the proteins and APA. 
3.4 DISCUSSION 
The biogenesis of eukaryotic RNA transcripts is made possible by a myriad of protein complexes 
that act in concert, orchestrating key tasks such as transcription, splicing, capping, 3′ end cleavage 
and polyadenylation. Although gene regulation by transcription is a widely studied process, the 
effects of other terminal processes such as polyadenylation that regulate transcript stability, 
transport and expression of RNA transcripts are poorly understood. Therefore, to help with the 
investigations of polyadenylation locations, 3′ UTRs, their different isoforms and usage, we built 
comprehensive maps of polyadenylation sites and quantified the usage of each polyadenylated gene 
isoform. The complete polyadenylation landscape is made publicly available through our web-
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portal, xPAD (Figure 10), which integrates the widely used UCSC genome browser48 to enable 
detailed investigation of any genomic region by intuitive queries involving gene name, keywords 
or gene position.  
 
Figure 10: Illustration of xPAD. xPAD integrates the UCSC genome browser to provide a web-interface to visualize 
both the precise polyadenylation locations of different isoforms, as well as their expression levels across tissues of 
interest. For brevity, many additional features such as evolutionary conservation (bottom track) and methylation marks, 
which are available via the UCSC browser panel (right) are not illustrated. 
xPAD integrates the UCSC genome browser to provide a web-interface to visualize both 
the precise polyadenylation locations of different isoforms, as well as their expression levels across 
tissues of interest. The complete gene structure of POLR2K highlights the utility of DRS; in both 
normal and tumor tissues, all polyadenylation sites exclusively occur in the 3′ UTR of the gene and 
within the sense strand, and the 3′ end of the reads (green/red bars) mapping to the long isoform 
matches within 2 nts of the 3′ UTR polyadenylation site. Normal breast contains 120 reads of long, 
and 109 reads of short isoforms, whereas breast tumor contains 257 reads of short isoform, which 
is upregulated, and 134 reads of long isoform that is almost unchanged. For brevity, many 
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additional features such as evolutionary conservation (bottom track) and methylation marks (not 
shown), which are available via the UCSC browser panel (right) are not illustrated.  
The different polyadenylated transcript isoforms could be regulated the transcriptional86,87 
as well as posttranscriptional82 levels, and the role of these two processes in polyadenylation may 
not be readily separable88. As most regulatory mechanisms that act in 3′ UTRs are thought to be 
repressive and not activating27, it is likely that if the causative factor is a canonical UTR-regulation 
mechanism such as that of miRNAs, then it must be downregulated in cancer. An alternative 
explanation is that non-canonical, isoform-dependent, UTR regulatory factors that do not repress, 
but activate (e.g. polyadenylation/cleavage proteins) short isoform levels are upregulated in cancer. 
Identification of potential isoform-dependent regulatory roles for Pabpc1, H3K36Me3, and the 
ATATAT motif that is linked to the yeast heterogeneous nuclear ribonucleoproteins (hnRNP)-like 
protein Hrp1 highlights the possibility of such isoform-dependent factors. Hrp1 contains two 
tandem RNA Recognition Motifs domain, an arrangement shared by various human hnRNPs. 
Although the protein sequence of Hrp1 is similar to all human hnRNPs, the Hrp1 mRNA sequence 
is most similar to hnRNPA3. Several hnRNP proteins seem upregulated in tumor, including one of 
the hnRNPA3 isoforms that is upregulated in four of the five tumor samples. Similarly, across all 
five samples, Pabpc1 reads in tumor samples are higher than that of normal tissues; manifesting 
greater than 2-fold up-regulation in lung and kidney samples. Given the emerging theme that 
polyadenylation is interlinked to other key processes such as transcription elongation and 
posttranscriptional regulation86,89, some of these regulatory marks such as H3K36Me3 may play a 
dual role in controlling both transcription and polyadenylation of the isoforms.  
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3.5 SUMMARY 
In summary, we built a comprehensive polyadenylation and APA map, which is made publically 
available as a webserver (johnlab.org/xpad) and as a UCSC track hub 
(http://www.johnlab.org/xpad/Hub/UCSC.txt). We have highlighted potential uses of the resource 
in studying polyadenylation-mediated gene regulation and generated new insights into the 
regulation of polyadenylation with an emphasis on gene isoform-dependent signatures in cancer. 
Although these observations will need to be followed up with more detailed studies, xPAD serves 
as a unique tool to investigate various questions in biology, relating to polyadenylation, APA-
mediated gene regulation, gene expression analysis, and discovery of new genes and gene 
isoforms. We aim to further expand xPAD with additional samples (tissue-types, cancer-subtypes, 
and cell lines), with the goal of defining gene-isoform signatures that may be useful for diagnosis 
or prognosis of specific human diseases, particularly in cancer61. These studies which provide cell-
type specific annotation and usage of 3′ UTRs are expected to also help other genome-wide studies 
of UTRs such as miRNA target analysis90,91, which could benefit by incorporating the expression 
levels of individual 3′ UTR isoforms.  
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4.0  CHARACTERIZING A NOVEL GROUP OF SHORT RNAS THAT ASSOCIATES 
WITH YB-1 
The highly conserved, multifunctional YB‐1 is a powerful breast cancer prognostic indicator. We 
report on a pervasive role of YB‐1 in which it associates with thousands of novel 
non‐polyadenylated, primarily intragenic, short RNAs termed shyRNAs that are further processed at 
their 5’/3’ termini to novel small RNAs. The shyRNA genomic locations are preferentially marked 
within 500 bases by chromatin regulatory factors. shyRNA genomic locations manifest a strong 
preference for histone modifications associated with active transcription and open chromatin 
configurations and are bound by multiple transcription factors that precisely span the locations. The 
shyRNAs are also enriched in known regulatory RNAs such as snoRNAs. One 3’‐modified, YB‐1 
associated RNA Shad1 (short RNA antisense to Dicer1) co‐localizes with YB‐1 under stress 
conditions and whose expression is closely linked with that of YB‐1. We propose that the majority 
of shyRNA loci represent alternative transcripts that are regulated by multiple factors in a cell‐type 
dependent manner and have evolved diverse cellular roles. 
4.1 INTRODUCTION 
Human Y‐box binding protein 1 (YB‐1) is a multifunctional protein that belongs to the highly 
conserved superfamily of cold shock domain (CSD) proteins known to bind both DNA and RNA89. 
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It is involved in many cellular functions including transcription/translation90,91, alternative splicing 
92,93, and mRNA degradation/processing in P‐bodies91,93,94. Inverse CAAT motifs, typically 
localized within promoter regions, serve as binding sites for YB‐1. Occupancy of YB‐1 at these 
sites can trigger either transcriptional activation through the recruitment of RNA polymerase II95 or 
repression via displacement of bound activator proteins96. YB‐1 has also been implicated as a 
protein partner in the splicing and transport of pre‐mRNAs97,98. In the cytoplasm, YB‐1 is also a 
component of the messenger ribonucleoprotein (mRNP) complexes formed by human Argonautes 
(AGO) which are central to small RNA‐mediated silencing99,100,101,102. In addition to the link 
between YB‐1 and mature microRNAs (miRNAs), YB‐1’s relatedness to lin‐28, a pluripotency 
factor and a processor of the let‐7 miRNA precursor103,104,105 suggests that it may have a broader 
role in small RNA processing and function than previously recognized. 
The role of YB‐1 in human biology and disease has been most thoroughly examined in 
cancer. YB‐1 expression levels have been shown to correlate with drug resistance and poor patient 
outcome in various cancers10618. Furthermore, YB‐1 may be a more powerful prognostic marker 
for relapse and survival in breast cancer patients than the commonly used markers Her‐2 and 
estrogen receptor107. Finally, YB‐1 expression levels have also been shown to correlate with 
malignant transformation and castrate resistant prostate cancer108. Although the mechanistic basis 
for YB‐1’s role in cancer has not been revealed, it is a partner of the p53 tumor suppressor protein 
and may therefore influence its many functions in tumor progression109. 
A pilot project to predict RNA binding proteins important to small RNA pathways led us to 
test whether YB‐1 associates with small RNAs in the androgen independent PC‐3 prostate cancer 
cell line. In recent years, various classes of small and long non‐coding RNAs have been identified 
in mammals110,111,112. In the most generalized form, genome‐wide profiling of transcription factor 
binding sites and RNA polymerase II (RNAPII) occupancy have revealed a large number of 
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unexpected loci that are far away from annotated transcription start sites113.  Studies in yeast have 
revealed that RNAPII can generate transcripts from sites quite far removed from gene‐associated 
promoters with different degrees of stability; these are categorized as cryptic unstable transcripts 
(CUTs)114 or stable uncharacterized transcripts115,116. The vast majority of CUTs and SUTs (95%) 
are predominately transcribed in the antisense orientation from bidirectional promoters and are 
frequently capped and polyadenylated. Similar RNAs that arise primarily from promoter/enhancer 
regions, termed TSSa‐RNAs117, eRNAs118, and the polyadenylated miRNAs119, exist in mammals. 
While the functions of these RNAs are largely unclear, other less characterized small/short RNAs, 
such as Y RNAs and vault RNAs are now recognized to have regulatory functions120,121. For 
example, Y RNAs (~100 nts) are highly conserved from bacteria to eukaryotes120,122 and all four 
human Y RNAs are more highly expressed in tumors123. The bulk of these non‐coding RNAs differ 
from mi/pi/siRNAs because they are thought to comprise diverse RNA pathways rather than 
conforming to a single molecular network. 
We found that YB‐1 associates with two distinct but related classes of RNAs in PC‐3 cells. 
These RNAs correspond to thousands of distinct short YB1‐associated RNAs (shyRNAs) and their 
cognate processed small RNAs that primarily match to the 5’ or 3’ terminal regions of shyRNAs. 
Many of the shyRNAs are also identical to known regulatory RNAs such as Y RNAs, vault RNAs 
and snoRNAs. The genomic locations of shyRNAs are bound by multiple transcription factors and 
polymerases similar to that of super‐enhancers. A n d  t he very large number (~230,000) of 
shyRNA genomic locations are primarily intragenic and surpasses the number of protein-coding 
genes by an order of magnitude suggesting that their purpose likely extends beyond the generation 
of mRNA transcripts. One of the shyRNAs derive from the anti‐sense strand of the Dicer1 gene, 
termed shad1 (short anti‐sense to Dicer1), and found to regulate the proliferation of PC‐3 cells.  
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4.2 METHODS 
4.2.1 Genomic analysis 
 
All sequence mapping and filtering were performed in house. Illumina FASTQ files were 
processed to retrieve sequences with Phred quality score to ensure a base call accuracy of 99%. The 
3’ adapter sequences and reads shorter than 15 nucleotides were removed using cutadapt. The 
filtered RNA reads were mapped to the human genome (GRCh37) using Bowtie. The mapped 
locations were then further filtered to only retain those reads that matched to a single unique 
location in the genome and were >1 RPKM. Neighboring (5’ to 5’ distance < 10 nts) reads from 
identical strands were considered as part of a single genomic cluster for annotations using UCSC 
Genome Browser and Bioconductor154,155. For the paired‐end sequencing reads, the libraries were 
normalized to the sequenced input RNA. Input RNAs that were > 2 fold enriched over YB‐1 RNAs 
was considered to be the control RNA sequences; YB‐1 RNAs that were > 2 fold enriched over 
input RNAs was considered to be the YB‐1 associated RNA sequences.  
4.2.2 Statistical analysis 
Publicly available (embargo free) ChIP‐seq data (ENCODE) of histone modifications(72 cell lines, 
682 samples) and transcription factors (88 cell lines, 218 transcription factors, 1284 samples) from 
the UCSC genome browser portal were used to establish the preference of various genomic features 
to shyRNA locations. As a control group, the input RNA locations with at least 2‐fold enrichment 
over YB‐1 and >1 RPKM (96,335 locations) were defined. An equivalent number based on RPKM 
of YB‐1 associated RNAs were selected. Bootstrapping analysis for YB‐1 to histone 
 56 
modification/TF binding site enrichment was performed by randomly sampling (with replacement, 
n=96,335) the described sets of both YB‐1 and control samples to yield 10 different datasets for 
each sample (YB‐1 or control). The distances to the closest histone modification or TF binding 
sites for each 5’ end of the YB‐1 associated RNAs or its equivalent control 5’ locations were 
calculated and binned (size = 200 nts). P‐values were computed using the two tailed t‐test based on 
the probability distribution of the YB‐1 and control bootstrapped data sets at position 0 (+/‐ 100 
nts). 
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Figure 11: Characteristics of YB-1 associated small and short RNAs. A) Length distribution of small RNAs 
immunoprecipitated with YB-1, hnRNP A/B (control), and rabbit IgG (control), based on Agilent Bioanalyzer 
(marker peak at 4 nts). (Experimented by Dr. Teresa Liu) B) Analysis of distinct sequences reveal that although 
mRNAs account for the majority of distinct reads they correspond to small fraction of all reads; such low abundance 
reads may correspond to mRNA breakdown products. In contrast, although distinct reads from introns is smaller than 
those from mRNAs, they correspond to the second most abundant group of small RNAs, next to miRNAs. C) Length 
distribution of reads from YB-1 immunoprecipitated and size (~80-100 nts) fractionated RNAs. D) The majority of 
shyRNAs reads derive from intragenic regions, followed by snoRNAs. 
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4.3 RESULTS 
4.3.1 Identified novel class of small RNAs associated with YB1 protein 
The small YB1-associated RNAs are sequenced with Illumina Hi-seq sequencer. The Illumina 
reads represent a total of 436,671 distinct genomic loci (18,871,897 reads) among which 226,412 
loci were cloned more than once. Among the genomically matching Illumina reads, 1.3 million 
reads (7%) maps to rRNAs and tRNAs, which may be due to the non-specific association of these 
abundant RNAs to YB-1. In other categories, 9.6 million reads (50.1%) map to miRNAs, 1.1 
million reads (6.2%) map to sense mRNA exons and 6.6 million reads (32%) to mRNA introns 
(Figure 11B). Among the 1,238 annotated mature miRNAs (miRBase), 553 (44%) were identified 
among the YB-1 associated small RNA fraction. A much higher proportion (69.8%) of the 381 
annotated snoRNAs match to YB-1 small RNAs, suggesting a substantial enrichment of 
sdRNAs12436. To investigate the possible presence of short RNAs indicated in in the YB-1 RNA 
Bioanalyzer profile (Figure 11A), the 80 to 100 nts fraction of RNAs immunoprecipitated with 
YB-1 was extracted and sequenced using the Illumina GAII sequencing approach. The transcripts 
were sequenced that ranged from 35 to 100 nts with a broad ~84-92 nts peak (Figure 11C). In 
total, we estimate to have sequenced 257,907 distinct high-quality shyRNA loci. Despite the 
differences in the RNA sizes, the proportions of shyRNAs that map to mRNA and intronic regions 
resembled that of YB-1 associated small RNAs (Figure 11D). The potential contamination by 
tRNAs represent a low percentage of all reads (11%), corresponding to 19.8% (124/625) of all 
annotated tRNA locations. In contrast, 73% (279/381) of snoRNAs are present among the shyRNA 
fraction. Recurrent enrichment of snoRNAs in both the short and small RNA fractions, over 
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similarly sized RNAs, adds support to the notion that YB-1 preferentially associates with both 
snoRNAs and their processed, smaller sdRNAs.  
4.3.2 Regulatory marks around shyRNA locations 
To gain insights into shyRNA biogenesis, we probed whether known RNAPII binding sites 
preferentially overlap with well-transcribed shyRNA genomic locations (>5 reads; 51,510 
locations). As controls, we used 10 different datasets of random genomic locations (random 
control), as well as 10 independent datasets of randomly selected exon locations (exon control). In 
general, while RNAPII binding sites are preferentially enriched at shyRNA locations relative to the 
random control, the exon controls are more enriched over the shyRNA locations. However, 
interrogation of GRO-seq125 data of transcriptionally engaged RNA polymerases (RNAP I-III) 
reveal that shyRNA locations across all five datasets are several fold more enriched than both 
random and exon control (Figure 12A). While the discrepancy between ChIP-seq data and GRO-
seq could be due to exonic RNAPII binding sites that are not used in either transcription initiation 
or productive elongation, it raised the possibility that shyRNA locations might preferentially 
associate with RNAPI/III genomic binding sites. However, since RNAPI activity is limited 
primarily to rRNAs126 and RNAPIII sites account for a small fraction (<2%) of shyRNA locations, 
it suggests that the majority of shyRNA transcripts are generated by RNAPII. 
To test for TF binding, we downloaded ENCODE127 ChIP-seq binding sites for 148 TFs 
across 433 experimental conditions and analyzed TF binding patterns at shyRNA locations. Several 
TFs emerged as significantly (p<10-10) overrepresented at shyRNA locations. Notably, CTCF, a 
well-known partner of YB-112840 is overrepresented at shyRNA locations in the T47D cell line at 
levels higher than that of both random and exon controls and accounts for ~6% of the shyRNA 
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locations (± 500 nts). In contrast, the pattern is reversed in other cell lines where CTCF occupancy 
pattern at shyRNA locations resemble that of random control locations (Figure 12A). In addition to 
known master regulators such as CTCF and p300, binding patterns of a few additional TFs are 
noteworthy, particularly Znf274, KAP1, ZBTB33, Bcl3, and Bcl11a.  
 
Figure 12: Specific transcription factor and histone modifications mark shyRNA loci in a cell-type dependent manner. A) 
shyRNA 5' locations are frequently located proximally (position 0) to protein binding sites in a context-dependent manner. The 
curves correspond to the distance distribution between the location of each feature and the nearest histone mark. Transcriptionally 
engaged polymerase locations (GRO-seq, left), are consistently more enriched towards shyRNAs in all cell lines analyzed. In 
contrast, regulatory factors such as CTCF manifest a cell-type dependent enrichment profile. B) Histone marks H3K36me3, and 
H4k20me1 are consistently overrepresented at shyRNA 5' locations, while the repressive mark H3k27me3 is under-represented at 
shyRNA locations. C) Examples of well-expressed shyRNA locations that precisely overlap with known binding sites of multiple 
TFs. Both locations reside within very low abundance genes (ANKRD30BL, UNC45B) as revealed by the lack of reads from both 
DRS and RNA-Seq of PC-3 cells.  
In comparison to both random and exon controls, shyRNA genomic locations manifest a 
strong preference (p < 10-10) towards H3K36Me3, consistently across all 42 datasets. Analysis of 
an additional 227 datasets spanning 12 histone marks, indicate that H4K20Me1 mark is also 
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preferentially enriched towards shyRNA genomic locations, at levels that surpass (p < 10-10) those 
of both random (p < 10-20) and exon controls (p < 10-10) across all 11 cell lines. A similar pattern 
was also found for H3K9Me1 in several cell lines. Consistent with the notion that shyRNA 
locations have evolved as platforms of active transcription, the repressive histone mark, 
H3K27Me3, associated with gene silencing or heterochromatin formation129,130 is significantly 
depleted at shyRNA genomic locations, occurring at levels that are generally lower than both 
random and exon controls across all experimental conditions (Figure 12B). A closer examination 
of several abundantly sequenced shyRNAs reveals an extraordinary convergence of several 
transcription factor binding sites including YB-1, and specific histone marks (H3K27Ac, 
H3K36Me3, and H4K20me1). The TF binding sites and histone marks frequently superpose 
precisely with shyRNA locations (Figure 12C). In summary, these observations indicate that 
shyRNA locations represent regions of the genome that are coordinately targeted in a context-
dependent manner by several transcription factors and histone marks. 
4.3.3 Transcription factors and histone modifications mark shyRNA locations 
To gain insights into shyRNA biogenesis, we probed for transcriptional regulators and chromatin 
remodeling at shyRNA locations as compared to input controls (Figure B1, B2). RNA polymerase 
II (RNAPII) ChIP‐seq data from several cell lines were obtained from Gene Expression Omnibus 
(GEO) and binding site locations overlapped with the shyRNA genomic locations. In the 88 cell 
lines examined, RNAPII was slightly enriched in the shyRNAs over the input controls even though 
an equal number of total reads were used from both fractions (Figure 13A). Multiple cell lines 
were used for comparison because data was unavailable in PC‐3 cell lines. An in‐depth 
interrogation using GRO‐seq data of all transcriptionally engaged RNA polymerases (RNAP I‐III), 
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the YB‐1 specific RNAs were more highly enriched (Figure 13B). While the differences between 
the ChIP‐seq and GRO‐seq data could be due to exonic RNAPII binding sites that are not used in 
transcription initiation or productive elongation, the observed preference cannot be attributed to 
shyRNA locations that might preferentially associate with RNAPI/III genomic binding sites. This is 
due to the fact that RNAPI activity is limited primarily to a small number of rRNAs133 and RNAPIII 
binding sites134 only account for a very small fraction (<2%) of shy RNA locations (Figure 13C). 
This suggests that while RNAPIII may contribute to some shyRNA synthesis, the majority of 
shyRNA transcripts are generated by RNAPII. 
Association of histone modifications with shyRNA locations provides an alternative method 
to gain insights into the underlying mechanisms that generate them. shyRNA genomic locations 
manifest a strong preference (p < 10‐20‐10‐35) towards H3K36me3, consistently across all 86 datasets 
(Figure 13D). Trimethylation at H3K36 results in a more open chromatin configuration and is 
generally found within the body of active genes specifically at active exons135. H3K27ac and 
H4K20me1 are two other histone modifications that mark transcriptional activation that are 
preferentially enriched in shyRNA genomic locations over input controls136,137(Figure 13E). 
H3K4me3, another activation modification normally marking the promoter regions of active genes, 
can be found overlapping shyRNA genomic locations, but the enrichment while statistically 
significant is not as striking over the control. Consistent with the hypothesis that shyRNA locations 
have evolved as platforms of active transcription, the repressive histone modification, H3K27me3, 
associated with gene silencing or heterochromatin formation is significantly depleted at shyRNA 
genomic locations over control138,139 (Figure 13F). 
The association of shyRNA locations with active transcription suggests that transcriptional 
regulators may also bind preferentially to these locations. ChIP‐seq binding sites for 148 
transcription factors (TF) across 433 experimental conditions were downloaded from ENCODE140. 
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Several TFs emerged as significantly overrepresented at shyRNA locations enriched over input 
controls. Notably, two master regulators of transcription, CTCF and p300, are known to interact 
with YB‐1 and are overrepresented at shyRNA locations in all cell lines examined96,141  (Figure 
13G). In conjunction with the association of shyRNAs with p300, shyRNA locations are also 
enriched at YY1 binding sites. YY1 is a zinc‐finger transcription factor that has the ability to 
recruit coactivators such as p300142. Other noteworthy TFs that bind to shyRNA locations include 
KAP1/TRIM28, ETS1 and MYC/MAX. KAP1 is a multifunctional protein implicated in the 
assembly of epigenetic machinery143,144. It can interact with other transcription factors to promote 
transcription or bind to promoters and repress gene expression144,145. ETS‐1 is a transcription factor 
commonly fused with androgen regulated genes in prostate cancer146. In PC‐3 cells, ETS‐1 
promotes cell proliferation and migration but not invasion147,148. ETS‐1 expression also correlates 
with poor prognosis in breast, ovarian and cervical cancers149,150,151. Interestingly, the TF binding 
sites enriched in shyRNAs are not evenly distributed among the shyRNA locations but rather 
precisely span shyRNA locations. The abundance of TFs at shyRNA locations combined with 
GRO‐seq suggest that shyRNA transcription start sites are likely proximal to their 5’ locations. 
These observations indicate that shyRNA locations represent regions of the genome that are 
targeted by several transcription factors and histone modifications, likely in a combinatorial 
manner. 
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Figure 13. Specific transcription factor and histone modifications mark shyRNA loci. A) shyRNA correlation with 
PolII over input control in K562 cells. B) shyRNA correlation with GRO‐seq data over input control in LNCaP cells. 
C) Input control correlation with PolIII over shyRNAs in K562. D) shyRNA correlation with H3K36me3 over input 
control. E) shyRNA correlation with H3K27ac and H4K20me3 over input control. F) Input control correlation with 
H3K27me3 over shyRNAs in Huvec cells. G. shyRNA correlation with CTCF and p300 in K562 cells over input 
control. 
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4.4 DISCUSSION 
The YB‐1 protein utilizes its DNA and RNA binding activity to influence various aspects of nucleic 
acid metabolism including DNA replication, transcription, mRNA splicing and export. We have 
identified a unique regulatory mechanism for YB‐1 that is mediated by a novel class of short RNAs 
termed shyRNAs and their processed small RNAs that specifically associate with YB‐1, perhaps as 
shown in one case by a direct interaction. All analysis that we have performed suggests that only a 
minor proportion of shyRNAs represent degradation products of longer non‐coding RNAs or 
mRNAs since the overlap between shy RNAs and RNA‐seq data from endo‐ and exonuclease 
knockdown cells are low. The biosynthesis of the YB‐1 associated RNAs we identified is 
unknown, but these RNAs correlate with not only PolII binding sites but also are in locations of 
active transcription, as determined by GRO‐seq and histone modifications.  Additionally, many of 
shyRNA locations are binding sites for multiple different transcriptional regulators.  The presence 
of multiple transcription factor binding sites along with fully assembled and initiated transcriptional 
complexes at regions where the chromatin status allows for active transcription supports the notion 
that shyRNAs may be derived by direct RNA PolII transcription. The possibility exists that, like 
TSSaRNAs, shyRNAs are byproducts related to RNAPII pausing 117,132. This is unlikely because 
the shyRNAs are not found in promoter regions, do not manifest divergent transcription at the 
locations, and are found within intronic regions. It is also possible that shyRNAs are a function of 
abortive transcription and YB‐1 associates with these RNAs as a clearance mechanism. This is also 
unlikely due to the conservation of the chromatin landscape at the shyRNA locations across all of 
the different cell lines we computationally examined. This is supported by the lack of a 5’ 
modification of Shad1 and the minimal overlap between these locations and RNAs degraded by 
endo‐ and exo‐nucleases. 
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The intersection between the transcription binding sites, histone modifications and the 
shyRNA locations also point to an interesting regulatory model with physiological implications. 
Recent studies have shown the presence of locations termed super‐enhancers where large numbers 
of transcription factor binding sites cluster along with activating histone modifications at promoter 
regions152,153. These super‐enhancer regions, found upstream of tumor associated genes in 
glioblastoma, multiple myeloma, and small cell lung cancer, often are more sensitive to chromatin 
regulators than regular enhancer regions152.   The association of all of these factors at the genomic 
location of shyRNAs could be a mechanism by which these RNAs are transcribed and regulated. 
We speculate that shyRNAs are products of active genomic regions that are “polymerase friendly” 
(Figure 7). Taken together with the observation that shyRNAs include many known regulatory 
short RNAs such as Y RNAs, pre‐miRNAs, and snoRNAs, these observations support the notion 
that shyRNAs represent a group of RNAs that share a common pathway but have evolutionarily 
acquired diverse cellular roles. 
4.5 SUMMARY 
In the study, we analyzed the property and relationship between two novel classes of YB-1 
associated RNAs. And we found that shyRNAs are primarily intragenic and further processed at 
their 5'/3' termini to novel small RNAs. We also noticed that the shyRNAs are derived from 
genomic locations highly enriched in binding sites of RNA polymerases, transcription factors such 
as CTCF, as well as activating histone marks H3K36Me3 and H4K20Me1. These enrichments 
frequently occur at levels much higher than control exon locations in a cell-type-specific manner. 
Furthermore, many shyRNA locations precisely overlap with reported binding sites of several 
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transcription factors and co-regulators, suggesting a context-dependent convergence of multiple 
transcriptional regulators at these locations. These results point to a mechanism that might control 
their biogenesis.  
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5.0  CONCLUSIONS 
The goal of the research is to investigate, annotate and understand the diverse roles of multiple 
RNAs in the genesis and regulation mechanism of human cancer with transcriptome analysis. To 
accomplish this goal, we first built a comprehensive polyadenylation map of human genome across 
major cancers, their cognate normal tissues and multiple cell lines, which could facilitate studies on 
3’ UTR isoforms and enable discoveries of important novel gene isoforms. Meanwhile, we have 
created the Expression and Polyadenylation Database (xPAD) as a web portal for the 
polyadenylation map. With these in place, we revealed polyadenylation patterns of non-coding and 
novel genes across major cancers and their cognate normal tissues and demonstrated that 
polyadenylation sites contain isoform-dependent regulatory marks 
Moreover, we discovered and characterized two novel classes of YB-1 associated RNAs 
and investigated possible biogenesis and regulation mechanism of them where we discovered that 
various transcription factors and histone modifications may mark the YB-1 associated RNA 
locations. 
Further, we designed and implemented an assembly-based compression tool, AbSEnT, with 
a de-Bruijn graph method, to squeeze the sequencing data,. We have demonstrated the feasibility 
and efficiency of the assembly-based algorithm and the tool. Also, when analyzing the distribution 
of word frequencies in sequencing data set, we have found a property of sequencing data set that is 
probably shared with books and social media data set, which might indicate that we could migrate 
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knowledge and experience in the natural language processing field to boost and facilitate the 
analysis of sequencing data. 
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Figure A1. Polyadenylation sites manifest similar overall characteristics across all tissues A-B) DRS reads 
predominantly match (bin size=10 nts) to annotated 3' ends of known genes across all tissue types in both normal (A) 
and tumor (B). C-D) Majority of DRS reads match to sense strand of transcriptionally active regions.  
 
Figure A2. Distribution of the locations of polyadenylation sites in sense and antisense intronic transcripts. The 
full-range of each intron is standardized to 0-100%, and the polyadenylation site location is with respect to the start of 
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the intron (sense strand; bin size=2%). For example, in normal breast, ~3% of pA sites that occur in sense introns are 
located within the first 2% of the full-length of intron. For each pair of sense and antisense distributions in either 
normal or tumor tissue, one-sided two-sample Kolmogorov-Smirnov test was performed to analyze if the observed 
preference of sense intronic transcripts to occur towards intron start is statistically significant in comparison to that of 
antisense intronic pA sites.  
 
Figure A3. Strong positional preference of ATATAT motif. The motif occurs 20 nts upstream of the 
polyadenylation site, exclusive to short isoforms. We note that a considerable proportion (~12% or ~400) of genes 
containing 3’ UTR isoforms used for the analysis seem affected by this motif.  
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Figure A4. Summary of transcriptional regulators bind to genomic locations. 
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Figure A5. Distance distribution of the H3K36Me3 and Pol2 marks next to short and long isoform 
polyadenylation sites in multiple cell lines.  
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APPENDIX B 
 
Figure B1.  Summary of chromatin remodeling factors and transcriptional regulators bind to shyRNA genomic 
locations. 
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Figure B2. Detail information of chromatin remodeling factors and transcriptional regulators bind to shyRNA 
genomic locations. 
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